Treatment patterns and clinical outcomes for multiple myeloma in Korean patients: a database study.

ABSTRACT:

Background

The treatment landscape for multiple myeloma (MM) has significantly progressed in recent decades.

Methods

We analyzed the treatment patterns and clinical outcomes in Korean patients using data from the National Health Insurance Service database. Patients diagnosed with MM between 2010 and 2018 were included. Survival analysis with a Cox regression model was performed.

Results

A total of 8,367 patients with MM were identified, from which 2,442 patients underwent stem cell transplantation (SCT). The mean patients' age at diagnosis was 67.1 years. Since 2011, the combination of a proteasome inhibitor (PI) and an alkylating agent has been most common, with a significant increase in the PI and immunomodulatory drug (IMiD) combination after 2015. The attrition ra

SUBMITTER: Yoon J 

PROVIDER: S-EPMC11869709 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature